Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap83.42M
Enterprise Value82.27M
Trailing P/E34.30
CSBR
(NASDAQ)Champions Oncology, Inc.
$5.77-- (--)
Loading... - Market loading
Champions Oncology (CSBR) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)1.46
Forward Price/Sales1.34
Price/Book (mrq)20.51
Price/Tangible Book (mrq)22.30
Price/FCF (ttm)15.16
Price/OCF (ttm)13.74
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.41
EV/Earnings33.00
EV/EBITDA20.72
EV/EBIT33.40
EV/FCF14.59
Stock Price
Current price, 52-week range, and moving averages
Current Price$5.77
1-Day Change2.87%
52-Week High$9.63
52-Week Low$5.50
52-Week Change-31.30%
YTD Change-11.19%
1-Year Change-33.16%
50-Day MA$6.23
200-Day MA$6.75
Avg Volume (30 day)2.71K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding14.46M
Book Value per Share$0.29
Net Cash per Share$0.48
FCF per Share$0.39
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin50.11%
EBITDA Margin (ttm)6.80%
EBIT Margin (ttm)4.22%
Operating Margin (ttm)4.22%
Pretax Margin (ttm)4.03%
Profit Margin (ttm)4.27%
FCF Margin (ttm)9.65%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)59.78%
Return on Assets (ttm)8.27%
Return on Invested Capital (ttm)282.24%
Return on Capital Employed (ttm)30.71%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue58.42M
Gross Profit29.28M
Operating Income2.46M
Pretax Income2.36M
Net Income2.49M
EBITDA3.97M
EBIT2.46M
Diluted EPS$0.17
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow6.22M
Capital Expenditures583.00K
Free Cash Flow5.64M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth16.49%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)30.16M
Cash & Securities (mrq)8.52M
Net Cash (mrq)6.99M
Net Cash per Share$0.48
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)5.27M
Working Capital (mrq)-809.00K
Total Equity (mrq)4.17M
Book Value per Share$0.29
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)0.96
Quick Ratio (mrq)0.96
Debt/Equity (mrq)1.26
Debt/EBITDA (ttm)1.33
Debt/FCF (ttm)0.93
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield2.92%
FCF Yield6.60%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score0.43
Piotroski F-Score7/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$1.06
Graham Upside/Downside-82.12%
Frequently Asked Questions About Champions Oncology Statistics
What are the key financial metrics for CSBR?
Champions Oncology, Inc. (CSBR) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CSBR's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Champions Oncology is overvalued or undervalued.
How do I read CSBR's profitability ratios?
Champions Oncology's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CSBR's debt ratios indicate?
The financial health section shows Champions Oncology's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CSBR's dividend analysis?
The dividend section covers Champions Oncology's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.